COST-EFFECTIVENESS ANALYSIS OF TRIPLE THERAPY WITH PEGINTERFERON, RIBAVIRIN, AND BOCEPREVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C VIRUS GENOTYPE 1 WITH SEVERE FIBROSIS UNDER ‘REAL-LIFE’ CONDITIONS: CO12
- Resource Type
- Academic Journal
- Source
- Basic & Clinical Pharmacology & Toxicology. Oct 01, 2014 115 Supp. 3:18-18
- Subject
- Language
- English
- ISSN
- 1742-7835